A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
Vinay Prasad, chief of the FDA’s Center for Biologics Evaluation and Research, is planning to publish a paper this month to ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...
ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newby in the Department of Genetic Medicine at the Johns Hopkins University School ...
A new study has revealed that the gene HMGN1 is a key driver of congenital heart defects (CHDs) in Down syndrome. Using ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
Martin Kampmann’s work, supported by the National Institutes of Science (NIH), maps cellular “decision points” that determine ...
Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.
Chowhound on MSN
Why Chocolate Is So Expensive (And How Researchers Might Put A Stop To Rising Prices)
Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...
A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback